<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We evaluated the potential of some recently proposed <z:mp ids='MP_0005039'>hypoxia</z:mp> markers, being <z:chebi fb="0" ids="25384">monocarboxylic acid</z:chebi> transporter 1 (MCT1), MCT4 and <z:chebi fb="0" ids="26274,32874">prolyl</z:chebi> hydroxylase 2 (PHD2); and a more established <z:mp ids='MP_0005039'>hypoxia</z:mp> marker, <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter-1 (GLUT-1), by testing the association with the exogenous marker pimonidazole </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: Paraffin embedded <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> sections of 20 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients were stained for blood vessels together with either pimonidazole or carbonic anhydrase-IX (CA-IX) and single stained for MCT1, MCT4, GLUT-1, and PHD2 </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of <z:hpo ids='HP_0000001'>all</z:hpo> markers was compared with expression of pimonidazole and micro-vessel density (MVD) and with disease-free survival (DFS) and overall survival (OS) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: No correlation was found between the different intrinsic <z:mp ids='MP_0005039'>hypoxia</z:mp> markers tested and pimonidazole </plain></SENT>
<SENT sid="4" pm="."><plain>A trend for high MCT1 expression in biopsies with low CA-IX expression was found (R = -0.45, p = 0.06) and also the expression of MCT1 was higher in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with a high MVD (R = 0.49, p = 0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>The more advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> showed a higher expression of GLUT-1 (p = 0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>A low CA-IX expression in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> correlated with better DFS (p = 0.03) and related to better OS (p = 0.07) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Although none of the tested intrinsic <z:mp ids='MP_0005039'>hypoxia</z:mp> markers correlated with pimonidazole staining, we confirmed the important role of both GLUT-1 and CA-IX for a more advanced pTNM (pathological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>) stage and DFS respectively </plain></SENT>
</text></document>